Putting Continuous Glucose Monitoring (CGM) into Practice: Certificate Program
Learn how to incorporate CGM in your practice to improve outcomes for the populations you serve ...
This assessment-based certificate program will provide a current CGM landscape review, the pros and cons of available devices, matching people with diabetes to the best device for them, overcoming barriers to implement CGM in practice, and reviewing and interpreting data to improve glycemic management.
Learners will have an increase in knowledge of how to incorporate CGM in their practice to improve outcomes for the populations they serve.
- Develop comfort with different CGM options and features
- Identify how to pair the person with diabetes to the CGM that is right for them
- List barriers and solutions to onboarding and sustaining CGM use
- Exhibit comfort with prescribing and providing education on the use of CGM
- Discuss coding and reimbursement for CGM
- Apply skills in data download and interpretation
- Explain data outcomes with persons with diabetes
- Who, What, and Why of Continuous Glucose Monitoring
- CGM in Your Practice
- Matching People and Devices
- Accessing CGM Data
- Transforming CGM Use into Clinical Outcomes
- Implementing CGM into Your Practice
- CGM Reimbursement
- Living with a CGM
- The Future Use of CGM
Each module includes copies of the presentation slides.
- Audio-visual presentation
Downloadable copies of slides
This self-paced online course is an application-based
This activity is designed for diabetes care and education specialists, including nurses,
dietitians, pharmacists, nurse practitioners, clinical nurse specialists, physicians, PAs, and other health care providers
interested in staying up to date on current practices of care for people with
diabetes and other related conditions.
This certificate is supported by an educational grant from Abbott.
Vivian Nnacho Ayuk, PharmD, CDCES
Pharmacy Manager, Flexcare Pharmacy
CEO, Sorogi Inc.
Amy Hess Fischl, MS, RDN, LDN, BC-ADM, CDCES
Program Coordinator, Teen Transition Program
Kovler Diabetes Center, University of Chicago
Diana Isaacs, PharmD, BCPS, BCACP, BC-ADM, CDCES, FADCES, FCCP
Endocrine Clinical Pharmacy Specialist
Anthony Pick, MD, CDCES
Lake Forest Hospital
Daniel Ruck, DNP, FNP, RN, BC-ADM, CDCES
Florence Endocrine Clinic
Gary Scheiner, MS, CDCES
Owner & Clinical Director
Integrated Diabetes Services LLC
support of improving patient care, the Association of Diabetes Care & Education
Specialists is jointly accredited by the Accreditation Council for Continuing
Medical Education (ACCME), the Accreditation Council for Pharmacy Education
(ACPE), and the American Nurses Credentialing Center (ANCC) to provide
continuing education for the healthcare team.
Council for Pharmacy Education (ACPE)
Universal Activity Number is JA4008258-0000-21-530-H01-P; JA4008258-0000-21-530-H01-T.
activity has been approved for 7.5 contact hours.
This statement contains information provided to NABP from
the Accreditation Council for Pharmacy Education (ACPE) via CPE
Monitor®. ACPE policy states paper and/or
electronic statements of credit may no longer be distributed directly to
learners as proof of ACPE credit. The official record of credit may be located
in the learner’s e-profile in CPE Monitor.
Medical Association (AMA)
of Diabetes Care & Education Specialists designates this enduring
material for a maximum of 7.5
AMA PRA Category 1 CreditsTM.
Physicians should claim only the credit commensurate with the extent of their
participation in the activity.
Nurses Credentialing Center (ANCC)
Association of Diabetes Care & Education Specialists designates this
activity for a maximum of 7.5 ANCC contact hours. This activity discusses 0.5 contact hours of pharmacotherapeutic
Association of Diabetes Care & Education Specialists is approved by the
California Board of Registered Nursing, Provider Number 10977, for 7.5 contact
Academy of PAs (AAPA)
Association of Diabetes Care & Education Specialists has been
authorized by the American Academy of PAs (AAPA) to award AAPA Category 1 CME
credit for activities planned in accordance with AAPA CME Criteria. This
activity is designated for 7.5 AAPA Category 1 CME credits. Approval is valid until 9/1/23. PAs should only claim credit
commensurate with the extent of their participation.
on Dietetic Registration (CDR)
Credentialed Practitioners will receive 7.5 Continuing Professional Education units (CPEU)
for completion of this activity.
Completion of this RD/DTR profession-specific or IPCE
activity awards CPEUs (One IPCE credit = One CPEU). If the activity is dietetics-related
but not targeted to RDs or DTRs, CPEUs may be claimed which are commensurate
with participation in contact hours (One 60 minute hour = 1 CPEU. RDs and DTRs
are to select activity type 102 in their Activity Log. Performance Indicator
selection is at the learner’s discretion.
Certified Diabetes Care and Education
To satisfy the requirements for renewal
of certification for the Certification Board for Diabetes Care and Education
(CBDCE), continuing education activities must be diabetes related and approved
by a provider on the CBDCE list of Approved Providers (www.cbdce.org). CBDCE does not approve
continuing education. The Association of Diabetes Care & Education
Specialists is on the CBDCE list of Approved Providers.
Board Certified Advanced Diabetes
ADCES is the administering body for the
Advanced Diabetes Management credentials. Continuing education programs offered
by ADCES can be used toward fulfilling BC-ADM Certification and recertification
Other Health Professionals
It is the responsibility of each
participant to determine if the program meets the criteria for re-licensure or
recertification for their discipline.
accordance with Joint Accreditation criteria, the Association of Diabetes Care
& Education Specialists (ADCES) must ensure that anyone in a position to
control the content of the educational activity (planners and
speakers/authors/discussants/moderators) has disclosed all relevant financial
relationships with any commercial interest.
Joint Accreditation also requires that
ADCES manage any reported conflict and eliminate the potential for bias during
the educational activity. Any conflicts noted below have been managed to our
satisfaction. The disclosure information is intended to identify any commercial
relationships and allow learners to form their own judgments. However, if you
perceive a bias during an activity, please report it on the evaluation.
Relevant disclosures (or lack thereof)
among educational activity planners and faculty are as follows:
Vivian Nnacho Ayuk, PharmD, CDCES - No conflicts of interest
Amy Hess Fischl, MS, RDN, LDN, BC-ADM, CDCES - Speakers Bureau: Abbott Diabetes Care, Xeris Pharmaceuticals
Diana Isaacs, PharmD, BCPS, BCACP, BC-ADM, CDCES, FADCES, FCCP - Speakers Bureau: Novo Nordisk, Xeris Pharmaceuticals, Medtronic, Insulet, Dexcom, Abbott
Anthony Pick, MD, CDCES - Speakers Bureau: Abbott, BI/Lilly, AstraZeneca, Novo Nordisk
Daniel Ruck, DNP, FNP, RN, BC-ADM, CDCES - No conflicts of interest
Gary Scheiner MS, CDCES - Advisory Board: Provention Bio, Eli Lilly, Medtronic, Xeris Pharmaceuticals, Capillary Biomedical
Jodi Lavin-Tompkins, MSN, RN, BC-ADM, CDCES – No conflicts of interest
Joanne Rinker, MS, RD, CDCES, LDN, FADCES – No conflicts of interest
The approval of this educational
offering by the ADCES does not imply endorsement of specific therapies,
treatments, or products discussed in the presentations.
Disclosure of Relevant Financial
Relationships and Mechanism to Identify and Resolved Conflicts of Interest
Undertaking review of the educational
activity to evaluate for potential bias, balance in presentation,
evidence-based content or other indicators of integrity, and absence of
will have access to this learning activity for a period of six months after you
enroll, or whenever the activity's CE credits expire (whichever comes
CE expiration date: 9/1/2023